Share on

Global Atrial Fibrillation Surgery Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Surgical Procedure, Product & Region - Industry Forecasts (2022 to 2027)

Published: January, 2022
ID: 3912
Pages: 175

Global Atrial Fibrillation Surgery Market Size (2022 to 2027)

The global atrial fibrillation surgery market size was valued at USD 1.71 billion in 2022. This market is forecasted to grow at a CAGR of 14.14% and reach USD 3.32 billion by 2027.

Atrial fibrillation, also called AFib or AF, doubles the risk of death. It increases the risk of stroke five to seven times. The increasing awareness about different treatment processes of the atrial fibrillation condition is boosting the market growth. It is estimated that 1 of the nine people below the age of 60 is affected by atrial fibrillation, directly resulting in the demand for the treatment. Patient with atrial fibrillation lives with an increased morbidity and mortality risk thus giving rise to the need for atrial fibrillation procedure.


Y-O-Y growth in the incidence of atrial fibrillation is majorly propelling the global atrial fibrillation surgery market growth.

As per the Centers for Disease Prevention and Control (CDC), the prevalence of AFib is predicted to range between 2.7 million to 6.1 million. This value is forecasted to hit 12.1 million by 2030, estimated to provide significant growth to the global article fibrillation market.

The growing prevalence of minimally invasive procedures is boosting up the growth rate of the market. Increasing expenditure on healthcare is also propelling the demand of the market. The cost of the procedure of atrial fibrillation surgery is low; thus, there is a considerable increase in the need for the procedure. There is a tremendous technological advancement in atrial fibrillation surgery, which is improving the cure rate of the patient. 


However, rising complications in the real-time application are hindering the demand of the market. The high cost for treatment procedures is additionally degrading the need of the atrial fibrillation market.

Impact of COVID-19 on the global atrial fibrillation surgery market:

The COVID-19 pandemic has had a significant effect on the global economy at various levels, including the healthcare sector. Due to the shutdown of production facilities, extreme shortages of raw materials, and the absence of potential human resources, the booming industry in health care research and development is likely to see a sharp drop in revenue during the lockdown period. A quivering or irregular heartbeat, also known as arrhythmia (Atrial fibrillation), can cause blood clots, strokes, cardiac failure, and other heart-related issues. For COVID-19 patients, AFib exacerbates a highly uncomfortable condition. Before the root cause of COVID-19 is tackled, it is generally far too late - until people are on a ventilator, in the ICU, struggling for their life - to fix an unresolved arrhythmia, which is often untreatable. Due to this, the demand for atrial fibrillation stroke therapy is widely competitive and has a positive growth in the market. Major players are concentrating their resources on working with the heart research center to create a better version of medicine to treat atrial fibrillation stroke and Covid-19 Patients.




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Surgical Procedure, Product, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa


This research report on the global atrial fibrillation surgery market has been segmented and sub-segmented based on the surgical procedure, product, and region.

Atrial Fibrillation Surgery Market - By Surgical Procedure:

  • Catheter Ablation procedure
  • Surgical Ablation
  • Maze procedure

Based on the surgical procedure, the Catheter Ablation Procedure segment held the largest share in 2019 and is estimated to grow with the highest CAGR during the forecast period. Factors like increasing demand for non-pharmaceutical treatments, growing patient awareness, and improved healthcare groundwork significantly push the global atrial fibrillation surgery market.

Atrial Fibrillation Surgery Market - By Product:

  • Catheter Ablation
  • Surgical Ablation

Based on the product, the Catheter ablation surgical devices are expected to be the largest segment. They are also likely to be the fastest-growing segment due to their high acceptance of surgical procedures.

Atrial Fibrillation Surgery Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Geographically, the North American regional market had dominated the global atrial fibrillation surgery market in the recent past and is predicted to continue the same during the forecast period due to the availability of highly advanced healthcare infrastructure and the adoption of highly advanced technologies. The presence of high volumes and complicated healthcare substructure, massive patient awareness, and increasing healthcare expenditure levels are expanding the market size in this region. The U.S. atrial fibrillation surgery market is projected to have a potential growth rate during the forecast period.

The European market has occupied the second largest market share in the atrial fibrillation surgery market during the forecast period. The market growth is due to the growing elder people population is one primary factor driving the market growth. The U.K is the leading nation in the market due to growing incidences of atrial fibrillation and rising healthcare awareness, and Germany will show lucrative growth over the period due to the increasing economy and adoption of the latest technologies.

The Asia Pacific is expected to be the fastest-growing segment due to the large geriatric population who has a high risk of heart diseases. Regulatory policies in Asia-Pacific countries are more flexible and business-friendly. It is due to the ubiquity of less strict regulations and data needs. China's atrial fibrillation surgery market will be growing at a healthy rate due to the presence of a huge patient pool and healthcare expenditure integrated with increasing awareness in people. Growth is due to a vast number of elder people population who are prone to high risk of heart diseases in countries like China and India.

Latin America region is observed to have a steady growth in the atrial fibrillation surgery market. Brazil is the leading nation in this region. The increase in Brazil is due to the development of the healthcare sector. The prevalence of minimally non-invasive surgeries is escalating the growth rate of the market.

The Middle East & Africa region shows a significant growth rate due to the increasing awareness of people. South Africa is to have a steady growth rate in the forthcoming years due to increasing knowledge of advanced treatment processes. The growth rate in Saudi Arabia is propelling due to increasing lifestyle changes and the growing obesity population.


Some of the notable players operating the global atrial fibrillation surgery market profiled in the report are Biosense Webster, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Articure, Inc., Medtronic, Inc., Cardima, Inc., Cardiofocus, Inc., nContact, Inc., and Biotronik SE & Co.


On May 12, 2020, the US FDA approved the next-generation CardioFocus Inc. HeartLight X3 Endoscopic ablation system to treat drug-refractory recurrent symptomatic paroxysmal atrial fibrillation. 

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 4255

Didn’t find what you’re looking for?

Find it too expensive?

Click for Request Sample